Skip to main content

Table 1 Demographic and clinical characteristics of participants (N = 300)

From: Attitudes and barriers towards participation in an acupuncture trial among breast cancer patients: a survey study

 

Total respondents

Willing to participate

P-value

 

N

%

 

Total

297

49.8

 

Age

   

  ≤55

71

60.6

0.037

  56-65

130

50.8

 

  >65

96

40.6

 

Race/Ethnicity

   

  White

250

51.2

0.28

  Non-White

47

42.6

 

Educational level

   

  High school or less

121

35.5

<0.001

  College

76

69.7

 

  Graduate/professional school

99

51.5

 

Employment

   

  Full-time

112

50.9

0.54

  Part-time

40

42.5

 

  Not currently

141

52.5

 

Stage

  

0.70

  I

99

45.4

 

  II

141

49.6

 

  III

32

53.1

 

Chemotherapy

  

0.17

  No

118

44.9

 

  Yes

179

53.1

 

Radiation therapy

  

0.017

  No

106

40.6

 

  Yes

191

55.0

 

Type of AI

  

0.056

  Exemestane

57

43.9

 

  Anastrazole

171

46.8

 

  Letrozole

69

62.3

 

Months on AI

23.5

21.7

0.11

Prior acupuncture use

  

0.004

  No

271

47.2

 

  Yes

26

76.9

 

CAM user

  

<0.001

  No

114

36.8

 

  Yes

183

57.9

 

Co-morbidity

  

0.037

  None

86

59.3

 

  Yes

211

46.0

 

Joint pain during past 7 days

  

0.038

  None

54

35.2

 

  Mild/moderate

189

51.8

 

  Severe or more

53

58.5

 
 

Mean for WTP

Std Dev.

 

Acupuncture expectancy scale

11.5

4.07

<0.001

  1. Abbreviations: AI, Aromatase Inhibitor; CAM, complementary and alternative medicine.
  2. *P-value obtained by Chi-2 for categorical and T-test for continuous outcomes.
  3. Not all cells add up to 300 due to missing data.